Premenopausal breast cancer: potential clinical utility of a multi-omics based machine learning approach for patient stratification
Autor: | Holger Fröhlich, Kristina Yeghiazaryan, Walther Kuhn, Christina Kehrer, Sabyasachi Patjoshi, Olga Golubnitschaja |
---|---|
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
business.industry Research Health Policy Biochemistry (medical) Medical laboratory medicine.disease Machine learning computer.software_genre Menopause 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Breast cancer 030220 oncology & carcinogenesis Drug Discovery medicine Premenopausal breast cancer Conventional chemotherapy Multi omics Artificial intelligence business Risk assessment computer Patient stratification |
Zdroj: | EPMA Journal. 9:175-186 |
ISSN: | 1878-5085 1878-5077 |
DOI: | 10.1007/s13167-018-0131-0 |
Popis: | BACKGROUND: The breast cancer (BC) epidemic is a multifactorial disease attributed to the early twenty-first century: about two million of new cases and half a million deaths are registered annually worldwide. New trends are emerging now: on the one hand, with respect to the geographical BC prevalence and, on the other hand, with respect to the age distribution. Recent statistics demonstrate that young populations are getting more and more affected by BC in both Eastern and Western countries. Therefore, the old rule “the older the age, the higher the BC risk” is getting relativised now. Accumulated evidence shows that young premenopausal women deal with particularly unpredictable subtypes of BC such as triple-negative BC, have lower survival rates and respond less to conventional chemotherapy compared to the majority of postmenopausal BC. WORKING HYPOTHESIS: Here we hypothesised that a multi-level diagnostic approach may lead to the identification of a molecular signature highly specific for the premenopausal BC. A multi-omic approach using machine learning was considered as a potent tool for stratifying patients with benign breast alterations into well-defined risk groups, namely individuals at high versus low risk for breast cancer development. RESULTS AND CONCLUSIONS: The study resulted in identifying multi-omic signature specific for the premenopausal BC that can be used for stratifying patients with benign breast alterations. Our predictive model is capable of discriminating individually between high and low BC-risk with high confidence (>90%) and considered of potential clinical utility. Novel risk assessment approaches and advanced screening programmes—as the long-term target of this project—are of particular importance for predictive, preventive and personalised medicine as the medicine of the future, due to the expected health benefits for young subpopulations and the healthcare system as a whole. |
Databáze: | OpenAIRE |
Externí odkaz: |